← 產業報告目錄
Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope, By Source (Nuclear Reactors, Cyclotrons), By Approach, By Application(Oncology, Non-Oncology), By End-User, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-25頁數 185報告編號 INSIGHTACE-9594325bce
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Radiotheranostics Market stood at USD 2.54 billion in 2024, and is expected to reach USD 8.73 billion by 2034, recording a CAGR of 6.0% from 2025 through 2034.
Radiotheranostics covers key industry insights & findings from the report:
The global radio theranostics market is expected to be driven by the expanding role of nuclear medicine in managing various chronic diseases and the . Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is underpinned by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiotheranostics Market Snapshot
Chapter 4. Global Radiotheranostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Radioisotope Estimates & Trend Analysis
5.1. by Radioisotope & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Radioisotope:
5.2.1. Technetium-99
5.2.2. Gallium-68
5.2.3. Iodine-131
5.2.4. Iodine-123
5.2.5. 18F
5.2.6. Y-90
5.2.7. Lutetium (Lu) 177
5.2.8. Copper (Cu) 67
5.2.9. Copper (Cu) 64
5.2.10. Others
Chapter 6. Market Segmentation 2: by Source Estimates & Trend Analysis
6.1. by Source & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2023 to 2031 for the following by Source:
6.2.1. Nuclear Reactors
6.2.2. Cyclotrons
Chapter 7. Market Segmentation 3: by Approach Estimates & Trend Analysis
7.1. by Approach & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2023 to 2031 for the following by Approach:
7.2.1. Targeted Therapeutic (Rx)
7.2.2. Companion Diagnostic (DX)
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2023 to 2031 for the following by Application:
8.2.1. Oncology
8.2.1.1. Thyroid Cancer
8.2.1.2. Neuroendocrine Cancer
8.2.1.3. Hepatocellular Carcinoma
8.2.1.4. Multiple Myeloma
8.2.1.5. Lymphoma
8.2.1.6. Others
8.2.2. Non-Oncology
8.2.2.1. Joint Infections
8.2.2.2. Arthritis
8.2.2.3. Bone Pain
8.2.2.4. Others
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2023 to 2031 for the following by End-user:
9.2.1. Hospitals & Clinics
9.2.2. Pharmaceutical & Biotechnology Companies
9.2.3. Others
Chapter 10. Radiotheranostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by Radioisotope, 2024-2031
10.1.2. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by Source, 2024-2031
10.1.3. North America Radiotheranostics Market revenue (US$ Billion) by Approach, 2024-2031
10.1.4. North America Radiotheranostics Market revenue (US$ Billion) by Application, 2024-2031
10.1.5. North America Radiotheranostics Market revenue (US$ Billion) by End-user, 2024-2031
10.1.6. North America Radiotheranostics Market Revenue (US$ Billion) Estimates and Forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2024-2031
10.2.2. Europe Radiotheranostics Market revenue (US$ Billion) by Source, 2024-2031
10.2.3. Europe Radiotheranostics Market revenue (US$ Billion) by Approach, 2024-2031
10.2.4. Europe Radiotheranostics Market revenue (US$ Billion) by Application, 2024-2031
10.2.5. Europe Radiotheranostics Market revenue (US$ Billion) by End-user, 2024-2031
10.2.6. Europe Radiotheranostics Market revenue (US$ Billion) by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2024-2031
10.3.2. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Source, 2024-2031
10.3.3. Asia-Pacific Radiotheranostics Market revenue (US$ Billion) by Approach, 2024-2031
10.3.4. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by Application, 2024-2031
10.3.5. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by End-user, 2024-2031
10.3.6. Asia Pacific Radiotheranostics Market revenue (US$ Billion) by country, 2024-2031
10.4. Latin America
10.4.1. Latin America Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2024-2031
10.4.2. Latin America Radiotheranostics Market revenue (US$ Billion) by Source, 2024-2031
10.4.3. Latin America Radiotheranostics Market revenue (US$ Billion) by Approach, 2024-2031
10.4.4. Latin America Radiotheranostics Market revenue (US$ Billion) by Application, 2024-2031
10.4.5. Latin America Radiotheranostics Market revenue (US$ Billion) by End-user, 2024-2031
10.4.6. Latin America Radiotheranostics Market revenue (US$ Billion) by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Radioisotope, 2024-2031
10.5.2. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Source, 2024-2031
10.5.3. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Approach, 2024-2031
10.5.4. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by Application, 2024-2031
10.5.5. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by End-user, 2024-2031
10.5.6. Middle East & Africa Radiotheranostics Market revenue (US$ Billion) by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Novartis AG
11.2.2. Telix Pharmaceuticals
11.2.3. Curium
11.2.4. ITM Isotope Technologies
11.2.5. Eli Lilly (via POINT Biopharma)
11.2.6. AstraZeneca (via Fusion Pharmaceuticals)
11.2.7. Radiopharm Theranostics
11.2.8. Advanced Accelerator Applications (AAA)
11.2.9. Ratio Therapeutics
11.2.10. Radionetics Oncology
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們